Neuroimaging in psychiatry

Irish Journal of Psychological Medicine

Volumn 24, Issue 3, 2007, Pages 86-88

  Cannon, Dara M ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID;

BRAIN BLOOD FLOW; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; EDITORIAL; FRONTAL CORTEX; GENOTYPE; GLUCOSE METABOLISM; GRAY MATTER; HUMAN; IRELAND; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PSYCHIATRIC DIAGNOSIS; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURFACE PROPERTY;

EID: 36049052072     PISSN: 07909667     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0790966700010363     Document Type: Editorial

References (29)

1. Hounsfield, G.N., Computerized transverse axial scanning (tomography). 1. Description of system. Br J Radiol, 1973. 46(552): p. 1016-22.
2. Drevets, W.C., D. Ongur, and J.L. Price, Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol Psychiatry, 1998. 3(3): p. 220-6, 190-1.
3. Macmaster, F.P., et al., Amygdala and Hippocampal Volumes in Familial Early Onset Major Depressive Disorder. Biol Psychiatry, 2007.
4. Okugawa, G., C. Tamagaki, and I. Agartz, Frontal and temporal volume size of grey and white matter in patients with schizophrenia : An MRI parcellation study. Eur Arch Psychiatry Clin Neurosci, 2007.
5. McDonald, C., et al., Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study. Br J Psychiatry, 2005. 186: p. 369-77.
6. McDonald, C., et al., Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol Psychiatry, 2004. 56(6): p. 411-7.
7. Fornito, A., et al., Surface-based morphometry of the anterior cingulate cortex in first episode schizophrenia. Hum Brain Mapp, 2007.
8. Sanacora, G., et al., Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry, 1999. 56(11): p. 1043-7.
9. Bhagwagar, Z., et al., Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol Psychiatry, 2007. 61(6): p. 806-12.
10. Yildiz-Yesiloglu, A. and D.P. Ankerst, Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Psychiatry Res, 2006. 147(1): p. 1-25.
11. Yildiz-Yesiloglu, A. and D.P. Ankerst, Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog Neuropsychopharmacol Biol Psychiatry, 2006. 30(6): p. 969-95.
12. Basser, P.J., J. Mattiello, and D. LeBihan, Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B, 1994. 103(3): p. 247-54.
13. Fujiwara, H., et al., Anterior and posterior cingulum abnormalities and their association with psychopathology in schizophrenia: A diffusion tensor imaging study. Schizophr Res, 2007.
14. Mori, T., et al., Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging. Psychiatry Res, 2007. 154(2): p. 133-45.
15. Drevets, W., et al., Subgenule prefrontal cortex abnormalities in mood disorders. Nature (Letters to Nature), 1997. 386: p. 824-827.
16. Knutson, B., et al., Dissociation of reward anticipation and outcome with event-related fMRI. Neuroreport, 2001. 12(17): p. 3683-7.
17. Owen, A.M., et al., Detecting awareness in the vegetative state. Science, 2006. 313(5792): p. 1402.
18. Cannon, D.M., et al., Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biol Psychiatry, 2006. 60(3): p. 207-17.
19. Meyer, J.H., et al., Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch Gen Psychiatry, 2004. 61(12): p. 1271-9.
20. Drevets, W.C., et al., Serotonin type-1A receptor imaging in depression. Nucl Med Biol, 2000. 27(5): p. 499-507.
21. Montgomery, A.J., et al., Extrastriatal D2 and striatal D2 receptors in depressive illness: pilot PET studies using [11C]FLB 457 and [11C]raclopride. J Affect Disord, 2007. 101(1-3): p. 113-22.
22. Cannon, D.M., et al., Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder. Arch Gen Psychiatry, 2006. 63(7): p. 741-7.
23. Cannon, D.M., et al., Elevated Serotonin Transporter Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [(11)C]DASB; Comparison with Bipolar Disorder. Biol Psychiatry, 2007.
24. McMahon, F.J., et al., Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet, 2006. 78(5): p. 804-14.
25. Martin-Soelch, C., et al., Lateralized dopaminergic response to reward in the human ventral striatum. Society for Neuroscience Annual Meeting Abstract Book, 2007.
26. Meyer, J.H., et al., Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Am J Psychiatry, 2004. 161(5): p. 826-35.
27. Saxena, S., et al., Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry, 2002. 59(3): p. 250-61.
28. Hamidi, M., W.C. Drevets, and J.L. Price, Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol Psychiatry, 2004. 55(6): p. 563-9.
29. Gaughran, F., et al., Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. Brain Res Bull, 2006. 70(3): p. 221-7